185 related articles for article (PubMed ID: 16534232)
1. Anemia management in chronic heart failure: lessons learnt from chronic kidney disease.
Besarab A; Soman S
Kidney Blood Press Res; 2005; 28(5-6):363-71. PubMed ID: 16534232
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of anaemia management in renal insufficiency and cardiac disease.
Silverberg D
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii7-12. PubMed ID: 12819294
[TBL] [Abstract][Full Text] [Related]
3. The interaction between heart failure and other heart diseases, renal failure, and anemia.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
[TBL] [Abstract][Full Text] [Related]
4. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
Iaina A; Silverberg DS; Wexler D
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
[TBL] [Abstract][Full Text] [Related]
5. Anemia and chronic heart failure implications and treatment options.
Anand IS
J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
[TBL] [Abstract][Full Text] [Related]
6. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations.
Silverberg DS; Wexler D; Blum M; Iaina A
Clin Nephrol; 2003 Jul; 60 Suppl 1():S93-102. PubMed ID: 12940539
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of anemia in cardiorenal disease.
Anand IS
Rev Cardiovasc Med; 2005; 6 Suppl 3():S13-21. PubMed ID: 16340934
[TBL] [Abstract][Full Text] [Related]
8. [Cardio-renal syndrome and anaemia].
Jakić M
Acta Med Croatica; 2009 Sep; 63 Suppl 1():38-45. PubMed ID: 20232550
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin in heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
[TBL] [Abstract][Full Text] [Related]
10. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
Silverberg DS; Wexler D; Iaina A
J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
[TBL] [Abstract][Full Text] [Related]
11. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Scherhag A; Schwartz D
Kidney Blood Press Res; 2005; 28(1):41-7. PubMed ID: 15489560
[TBL] [Abstract][Full Text] [Related]
12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
13. Congestive heart failure-related anemia and a role for erythropoietin.
Akram K; Pearlman BL
Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
[TBL] [Abstract][Full Text] [Related]
14. Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed?
Berns JS
Semin Dial; 2005; 18(1):22-9. PubMed ID: 15663760
[TBL] [Abstract][Full Text] [Related]
15. Anemia: the point of convergence or divergence for kidney disease and heart failure?
Kazory A; Ross EA
J Am Coll Cardiol; 2009 Feb; 53(8):639-47. PubMed ID: 19232895
[TBL] [Abstract][Full Text] [Related]
16. [Erythropoesis-stimulating agents: past, present and future].
Kes P; Basić-Jukić N
Acta Med Croatica; 2009 Sep; 63 Suppl 1():3-6. PubMed ID: 20235351
[TBL] [Abstract][Full Text] [Related]
17. [Anemia as a risk factor for CKD and CVD].
Tsuruya K; Hirakata H
Nihon Rinsho; 2008 Sep; 66(9):1786-93. PubMed ID: 18788410
[TBL] [Abstract][Full Text] [Related]
18. Anemia and the heart in chronic kidney disease.
Zalunardo N; Levin A
Semin Nephrol; 2006 Jul; 26(4):290-5. PubMed ID: 16949467
[TBL] [Abstract][Full Text] [Related]
19. [Anemia in chronic kidney disease and its cardiovascular implications].
Cases A; Coll E; Collado S
Med Clin (Barc); 2009 May; 132 Suppl 1():38-42. PubMed ID: 19460479
[TBL] [Abstract][Full Text] [Related]
20. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
Singh AK; Hertello P
Nephrol Nurs J; 2005; 32(2):199-206; quiz 207-8. PubMed ID: 15889804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
